These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 31255368)

  • 21. Biological and molecular characteristics of Mycobacterium tuberculosis clinical isolates with low-level resistance to isoniazid in Japan.
    Abe C; Kobayashi I; Mitarai S; Wada M; Kawabe Y; Takashima T; Suzuki K; Sng LH; Wang S; Htay HH; Ogata H
    J Clin Microbiol; 2008 Jul; 46(7):2263-8. PubMed ID: 18508939
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis.
    Hazbón MH; Brimacombe M; Bobadilla del Valle M; Cavatore M; Guerrero MI; Varma-Basil M; Billman-Jacobe H; Lavender C; Fyfe J; García-García L; León CI; Bose M; Chaves F; Murray M; Eisenach KD; Sifuentes-Osornio J; Cave MD; Ponce de León A; Alland D
    Antimicrob Agents Chemother; 2006 Aug; 50(8):2640-9. PubMed ID: 16870753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Defining of gene mutations and minimal inhibitory concentrations in isoniazid resistant Mycobacterium tuberculosis isolates].
    Yıldırım E; Uzun M
    Mikrobiyol Bul; 2017 Oct; 51(4):305-316. PubMed ID: 29153061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of combined gene mutations in inhA and ahpC genes on high levels of isoniazid resistance amongst katG non-315 in multidrug-resistant tuberculosis isolates from China.
    Liu L; Jiang F; Chen L; Zhao B; Dong J; Sun L; Zhu Y; Liu B; Zhou Y; Yang J; Zhao Y; Jin Q; Zhang X
    Emerg Microbes Infect; 2018 Nov; 7(1):183. PubMed ID: 30446638
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of GenoType MTBDRplus for the detection of drug-resistant Mycobacterium tuberculosis on isolates from Karachi, Pakistan.
    Siddiqui S; Brooks MB; Malik AA; Fuad J; Nazish A; Bano S; Becerra MC; Hussain H
    PLoS One; 2019; 14(8):e0221485. PubMed ID: 31425565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can inhA mutation predict ethionamide resistance?
    Vadwai V; Ajbani K; Jose M; Vineeth VP; Nikam C; Deshmukh M; Shetty A; Soman R; Rodrigues C
    Int J Tuberc Lung Dis; 2013 Jan; 17(1):129-30. PubMed ID: 23146620
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The occurrence and frequency of genomic mutations that mediate Isoniazid and Rifampicin resistance in
    Kumwenda GP; Chipungu G; Sloan DJ; Kaimila Y; Chiumya K; Pangani H
    Malawi Med J; 2018 Mar; 30(1):1-5. PubMed ID: 29868151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of Mycobacterium tuberculosis cross-resistance to isoniazid, rifampicin and levofloxacin with their respective structural analogs.
    Imperiale BR; Di Giulio ÁB; Adrián Cataldi A; Morcillo NS
    J Antibiot (Tokyo); 2014 Nov; 67(11):749-54. PubMed ID: 24894185
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A katG S315T or an ahpC promoter mutation mediate Mycobacterium tuberculosis resistance to 2-thiophen carboxylic acid hydrazide, an inhibitor resembling the anti-tubercular drugs Isoniazid and Ethionamide.
    Franceschelli JJ; Belardinelli JM; Tong P; Loftus B; Recio-Balsells A; Labadié GR; Gordon SV; Morbidoni HR
    Tuberculosis (Edinb); 2018 Sep; 112():69-78. PubMed ID: 30205971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic Mutations Associated with Isoniazid Resistance in Mycobacterium tuberculosis in Mongolia.
    Narmandakh E; Tumenbayar O; Borolzoi T; Erkhembayar B; Boldoo T; Dambaa N; Burneebaatar B; Nymadawa N; Mitarai S; Jav S; Chiang CY
    Antimicrob Agents Chemother; 2020 Jun; 64(7):. PubMed ID: 32312782
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid genotypic assays to identify drug-resistant Mycobacterium tuberculosis in South Africa.
    Evans J; Stead MC; Nicol MP; Segal H
    J Antimicrob Chemother; 2009 Jan; 63(1):11-6. PubMed ID: 18940875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GenoType MTBDRplus assay for screening and characterization of isoniazid and rifampicin resistance-associated mutations in multidrug-resistant Mycobacterium tuberculosis from India.
    Sethi S; Yadav R; Singh S; Khaneja R; Aggarwal A; Agarwal P; Behera D
    Lett Appl Microbiol; 2017 Nov; 65(5):373-380. PubMed ID: 28793376
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of isoniazid and rifampicin resistance in Mycobacterium tuberculosis isolates in Morocco using GenoType
    Ennassiri W; Jaouhari S; Sabouni R; Cherki W; Charof R; Filali-Maltouf A; Lahlou O
    J Glob Antimicrob Resist; 2018 Mar; 12():197-201. PubMed ID: 28993300
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of discrepant results between the Genotype
    Jo KW; Yeo Y; Sung H; Kim MN; Shim TS
    Respir Med; 2017 Jan; 122():12-17. PubMed ID: 27993285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug resistance-conferring mutations in Mycobacterium tuberculosis from pulmonary tuberculosis patients in Southwest Ethiopia.
    Tadesse M; Aragaw D; Dimah B; Efa F; Abdella K; Kebede W; Abdissa K; Abebe G
    Int J Mycobacteriol; 2016 Jun; 5(2):185-91. PubMed ID: 27242230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variants of katG, inhA and nat genes are not associated with mutations in efflux pump genes (mmpL3 and mmpL7) in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from India.
    Unissa AN; Dusthackeer VNA; Kumar MP; Nagarajan P; Sukumar S; Kumari VI; Lakshmi AR; Hanna LE
    Tuberculosis (Edinb); 2017 Dec; 107():144-148. PubMed ID: 29050763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutations of rpoB, katG, inhA and ahp genes in rifampicin and isoniazid-resistant Mycobacterium tuberculosis in Kyrgyz Republic.
    Isakova J; Sovkhozova N; Vinnikov D; Goncharova Z; Talaibekova E; Aldasheva N; Aldashev A
    BMC Microbiol; 2018 Mar; 18(1):22. PubMed ID: 29566660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular characterization of isoniazid-resistant Mycobacterium tuberculosis isolates from Xi'an, China.
    Zhou A; Nawaz M; Duan Y; Moore JE; Millar BC; Xu J; Yao Y
    Microb Drug Resist; 2011 Jun; 17(2):275-81. PubMed ID: 21388297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Evaluation of the genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in clinical Mycobacterium tuberculosis complex clinical isolates].
    Aslan G; Tezcan S; Emekdaş G
    Mikrobiyol Bul; 2009 Apr; 43(2):217-26. PubMed ID: 19621606
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genotypic analysis of isoniazid and rifampin resistance in drug-resistant clinical Mycobacterium tuberculosis complex isolates in southern Turkey.
    Aslan G; Tezcan S; Serin MS; Emekdas G
    Jpn J Infect Dis; 2008 Jul; 61(4):255-60. PubMed ID: 18653964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.